Long-term incidence of posterior capsular opacification in patients with non-infectious uveitis
- PMID: 35277585
- PMCID: PMC8917155
- DOI: 10.1038/s41598-022-08325-7
Long-term incidence of posterior capsular opacification in patients with non-infectious uveitis
Abstract
Little is known about the long-term incidence of posterior capsule opacification (PCO) after cataract surgery in patients with uveitis. This retrospective study included 211 eyes of 146 patients with non-infectious uveitis who underwent cataract surgery and implantation of an Acrysof SN60WF (Surface: plasma-treated, Optic and Haptic: hydrophobic acrylic), iSert XY-1 (Surface: UV-ozone-treated, Optic and Haptic: hydrophobic acrylic), or iSert 251/255 (Surface: UV-ozone-treated, Optics: hydrophobic acrylic, Haptic: polymethyl methacrylate). The cumulative incidences of PCO and subsequent yttrium-aluminum-garnet (Nd:YAG) capsulotomy over the 5-year follow-up were analyzed, and patients who were implanted with different intraocular lenses (IOLs) were compared. Mixed-effects Cox proportional hazard models showed that, compared with the Acrysof group, the iSert XY-1 group had higher risks of PCO (adjusted HR, 7.26; 95% CI, 1.82-28.8) and Nd:YAG capsulotomy (adjusted HR, 6.50; 95% CI, 1.55-27.2). Similar results were obtained when the Acrysof group was compared with the iSert 251/255 group for PCO (adjusted HR, 8.22; 95% CI, 2.35-28.7) and Nd:YAG capsulotomy (adjusted HR, 8.26; 1.90-36.0). These data suggest that a plasma-treated surface, hydrophobic acrylic optic and hydrophobic acrylic haptic, of the IOL could enhance biocompatibility even under inflammatory conditions, thus suppressing PCO development.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Three-year incidence of Nd:YAG capsulotomy and posterior capsule opacification and its relationship to monofocal acrylic IOL biomaterial: a UK Real World Evidence study.Eye (Lond). 2018 Oct;32(10):1579-1589. doi: 10.1038/s41433-018-0131-2. Epub 2018 Jun 11. Eye (Lond). 2018. PMID: 29891902 Free PMC article.
-
Posterior Capsule Opacification With Two Hydrophobic Acrylic Intraocular Lenses: 3-Year Results of a Randomized Trial.Am J Ophthalmol. 2020 Sep;217:224-231. doi: 10.1016/j.ajo.2020.04.011. Epub 2020 Apr 23. Am J Ophthalmol. 2020. PMID: 32335056 Clinical Trial.
-
5 year incidence of YAG capsulotomy and PCO after cataract surgery with single-piece monofocal intraocular lenses: a real-world evidence study of 20,763 eyes.Eye (Lond). 2020 May;34(5):960-968. doi: 10.1038/s41433-019-0630-9. Epub 2019 Oct 15. Eye (Lond). 2020. PMID: 31616057 Free PMC article.
-
Glistenings, anterior/posterior capsular opacification and incidence of Nd:YAG laser treatments with two aspheric hydrophobic acrylic intraocular lenses - a long-term intra-individual study.Acta Ophthalmol. 2017 Nov;95(7):671-677. doi: 10.1111/aos.13444. Epub 2017 Mar 30. Acta Ophthalmol. 2017. PMID: 28371401 Clinical Trial.
-
Comparison of the Incidence of Nd:YAG Laser Capsulotomy Based on the Type of Intraocular Lens.Medicina (Kaunas). 2023 Dec 14;59(12):2173. doi: 10.3390/medicina59122173. Medicina (Kaunas). 2023. PMID: 38138276 Free PMC article.
Cited by
-
Effect of surface-modified intraocular lenses on long-term postoperative inhibition of posterior capsule opacification.Heliyon. 2024 Jun 14;10(12):e33006. doi: 10.1016/j.heliyon.2024.e33006. eCollection 2024 Jun 30. Heliyon. 2024. PMID: 39022042 Free PMC article.
-
A bibliometric and visualized analysis of the pathogenesis of cataracts from 1999 to 2023.Heliyon. 2024 Feb 13;10(4):e26044. doi: 10.1016/j.heliyon.2024.e26044. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38390089 Free PMC article.
-
Long-term outcomes of small-incision cataract surgery in patients with uveitis.Indian J Ophthalmol. 2022 Nov;70(11):3927-3932. doi: 10.4103/ijo.IJO_1571_22. Indian J Ophthalmol. 2022. PMID: 36308129 Free PMC article.
-
Complete Blood Cell Count-Derived Inflammation Biomarkers and the Need for Laser Capsulotomy Due to Posterior Capsule Opacification Following Cataract Surgery.J Inflamm Res. 2024 Sep 5;17:6075-6082. doi: 10.2147/JIR.S473655. eCollection 2024. J Inflamm Res. 2024. PMID: 39253563 Free PMC article.
-
Ophthalmic Use of Targeted Biologics in the Management of Intraocular Diseases: Current and Emerging Therapies.Antibodies (Basel). 2024 Oct 11;13(4):86. doi: 10.3390/antib13040086. Antibodies (Basel). 2024. PMID: 39449328 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical